Brain scans reveal why some kids Don't overeat after watching food commercials
NCT ID NCT05073185
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at why some children are less affected by food advertising than others. Researchers will use brain scans and eating tests in 200 kids aged 7-9 to find traits that protect against overeating. The goal is to understand what makes certain children resilient to food-cue triggered overeating, which could help prevent childhood obesity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could reveal why some children are naturally resilient to food advertising, pointing toward new ways to prevent childhood obesity.
- What could go wrong
- This is an observational study, not a treatment trial. It may only describe differences without leading to a practical intervention, and results may not apply to all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Pennsylvania State University
RECRUITINGUniversity Park, Pennsylvania, 16802, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test